|
C14ORF135 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.59210000019827E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.28790000015245E-07 |
| Normal-vs-Stage2 |
4.203200E-03 |
| Normal-vs-Stage3 |
1.358440E-04 |
| Normal-vs-Stage4 |
9.72080000000153E-05 |
| Stage1-vs-Stage2 |
8.807800E-01 |
| Stage1-vs-Stage3 |
6.572200E-01 |
| Stage1-vs-Stage4 |
5.670400E-01 |
| Stage2-vs-Stage3 |
5.916600E-01 |
| Stage2-vs-Stage4 |
4.476200E-01 |
| Stage3-vs-Stage4 |
7.431200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.39160000004013E-06 |
| Normal-vs-AfricanAmerican |
3.90449999998488E-07 |
| Normal-vs-Asian |
4.792000E-04 |
| Caucasian-vs-AfricanAmerican |
2.686400E-01 |
| Caucasian-vs-Asian |
5.052000E-01 |
| AfricanAmerican-vs-Asian |
6.299000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.68180000113128E-08 |
| Normal-vs-Female |
2.362700E-03 |
| Male-vs-Female |
3.188400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.938600E-03 |
| Normal-vs-Extreme_Weight |
4.6663999999641E-06 |
| Normal-vs-Obese |
8.11070000000802E-05 |
| Normal-vs-Extreme_Obese |
2.031800E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.855800E-01 |
| Normal_Weight-vs-Obese |
9.666800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.736200E-01 |
| Extreme_Weight-vs-Obese |
5.751800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.306600E-01 |
| Obese-vs-Extreme_Obese |
6.761200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.205800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.42510000000507E-05 |
| Normal-vs-Age(61-80Yrs) |
1.82600000009359E-07 |
| Normal-vs-Age(81-100Yrs) |
4.05210000000711E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.773600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.609200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.035580E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.184200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.897800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.398200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.15650000001677E-06 |
| Normal-VS-Type2 PRCC |
1.11270000002772E-06 |
| Normal-VS-KIRP CIMP |
2.995400E-01 |
| Normal-VS-Unclassified PRCC |
3.499500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.136020E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.350000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.699000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.925600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.047000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.963600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.91010000039071E-08 |
| Normal-vs-N1 |
2.158400E-02 |
| Normal-vs-N2 |
4.13891143580258E-13 |
| N0-vs-N1 |
5.290100E-02 |
| N0-vs-N2 |
6.85579999992747E-07 |
| N1-vs-N2 |
1.54076999999697E-05 |
|
|
